Oral Answers to Questions Debate
Full Debate: Read Full DebateAlison Thewliss
Main Page: Alison Thewliss (Scottish National Party - Glasgow Central)Department Debates - View all Alison Thewliss's debates with the Department for Exiting the European Union
(6 years, 5 months ago)
Commons ChamberMy hon. Friend asks me an interesting question, which is probably more appropriate for a Treasury Minister to answer, but I recognise its importance. The UK is stepping up investment in R&D with our target to ensure that 2.4% of GDP is spent on it. That will make us one of the leading countries in the world for investment in research.
The Rheumatoid Arthritis Pathogenesis Centre of Excellence in Glasgow relies not only on the movement of people and talent but on the movement of medical samples across borders. What will the Minister do to ensure that medical samples can travel unfettered across the EU after Brexit?
The hon. Lady raises a very important point. Having visited the university in Glasgow to talk about some of these issues, I recognise the world-leading research that takes place there. Of course we want to ensure that patients in the UK and the EU continue to benefit from the exchange between us. That is why we have talked not only about co-operation in science but about the benefits of the UK’s continued participation through associate membership of the European Medicines Agency.
The UK Government have long used the fact of being in the EU as an excuse for not implementing the international code of marketing of breast-milk substitutes. Will the Government make it their policy to adopt that code after we leave the EU?
The hon. Lady has raised that point before in these questions. She will appreciate that that is not necessarily a question for this Department, but she points to an area in which the UK may have greater flexibility in the future, which we should welcome.